Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women

Using a highly sensitive chemiluminescent enzyme immunoassay, we have evaluated the measurement of serum prostate-specific antigen (PSA) as a potential diagnostic test for differentiation between women with breast cancer and those with benign breast disease. In a controlled study consisting of 284 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Romppanen, J, Keskikuru, R, Kataja, V, Eskelinen, M, Kosma, V-M, Savolainen, K, Uusitupa, M, Mononen, I
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362737/
https://www.ncbi.nlm.nih.gov/pubmed/10188910
http://dx.doi.org/10.1038/sj.bjc.6690252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362737/
https://www.ncbi.nlm.nih.gov/pubmed/10188910
http://dx.doi.org/10.1038/sj.bjc.6690252

Ejemplares similares